NovoCure (NVCR) Stock Is Trending Overnight - Here's What You Should Know
NovoCure Ltd (NASDAQ:NVCR) shares are trending on Thursday.
Shares of the oncology company surged 29.52% to $13.60 in after-hours trading on Wednesday after the Food and Drug Administration approved Optune Pax for the treatment of locally advanced pancreatic cancer.
First Approval In Three Decades
The approval marks the first new treatment for locally advanced pancreatic cancer in nearly 30 years, according to the company’s announcement.
Optune Pax, which is a portable therapeutic device that delivers Tumor Treating Fields (TTFields) noninvasively through wearable arrays, is approved for use with gemcitabine and nab-paclitaxel chemotherapy.
Frank Leonard, Novocure's CEO, said, “This is a proud moment for Novocure and we look forward to bringing Optune Pax to patients and the healthcare providers who care for them.”
Dr. Vincent Picozzi, PANOVA-3 trial investigator, said Optune Pax “has the potential to be practice changing for the treatment of patients with locally advanced pancreatic cancer.”
Phase 3 Trial Results
The PANOVA-3 trial, an open-label Phase 3 study, evaluated Optune Pax in combination with gemcitabine and nab-paclitaxel against treatment with gemcitabine and nab-paclitaxel alone in 571 patients.
Median overall survival was 16.2 months, compared with 14.2 months, representing a two-month improvement, with a hazard ratio of 0.82 (p=0.039).
According to the company, the time to pain progression was extended to 15.2 months, compared with 9.1 months. Device-related skin reactions occurred in 76.3% of patients, most of which were Grade 1 or 2.
Trading Metrics, Technical Analysis
The Relative Strength Index (RSI) of NovoCure stands at 31.55.
With a market capitalization of $1.18 billion, the Switzerland-based company has a 52-week high of $22.95 and a 52-week low of $9.82.
The stock of the biotech has fallen 50.50% over the past year.
It is currently positioned about 5.2% above its 52-week low, near the low end.
The long-term trend and weak positioning suggest that, although there may be short-term opportunities, overall sentiment remains negative, and traders should monitor for signs of either a reversal or continued weakness.
Price Action: On Wednesday, NVCR closed at $10.50, up 0.29%, according to Benzinga Pro data.
Benzinga’s Edge Stock Rankings indicate that NVCR has a negative price trend across all time frames.
Photo Courtesy: Connect world on Shutterstock.com
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Intel CEO: CPU only meets 50% of demand, 14A to start production in Q1 next year, new architecture may reduce inference power consumption to 1/15 of GPU
Intel CEO Pat Gelsinger stated that the era of AI agents has triggered an explosion in CPU demand, and Intel is currently able to meet only about 50% of its customers' supply needs, with several tech giant CEOs calling to secure supply. In terms of manufacturing process, the 18A node is now in full mass production, while the 14A node will begin production in the first quarter of next year. By opening up factory data, yield rates are improving by about 7% annually. Additionally, he is advancing neuromorphic computing to address energy consumption bottlenecks and expects quantum computing to have a substantial industrial impact within 3 to 5 years.
Reportedly, the US urges Japan to "increase" defense spending; Tokyo considers a 3.5% GDP target, bond market and yen come under pressure first
Under pressure from the United States, Japan is considering setting a new medium-term defense spending target, planning to increase its defense expenditure to 3.5% of GDP to align with NATO and other U.S. allies.
The logic of "cheap yen financing" is changing! Funds are reallocating "carry trades" as Swiss franc and Swedish krona compete for the funding currency position
The appeal of yen financing has diminished, and carry traders have recently turned their attention to the franc and the krona. With the yen’s recent surge making it a less reliable investment option, currencies such as the Swedish krona and Swiss franc are becoming primary funding choices for carry trades.
Crypto prices
More
